Stent thrombosis (ST) is a rare but severe complication of coronary procedures with high
mortality, high relapse rate and a very complex pathophysiology. An individual's …

Background: The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent
(DES) implantation is unclear, and its risks and benefits may vary according to DES …

Guidelines, Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dual antiplatelet therapy, Acute
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …

Importance The current recommendation is for at least 12 months of dual antiplatelet therapy
after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet …

Background: The optimal duration of dual antiplatelet therapy (DAPT) following second-
generation drug-eluting stent (DES) implantation is still debated. Objectives: The aim of this …

Background: The use of drug-eluting stents (DES) in patients at high risk of bleeding or
thrombosis has not been prospectively studied; limited data are available in patients who …

Objective To assess differences in estimated treatment effects for mortality between
observational studies with routinely collected health data (RCD; that are published before …

Objective To evaluate the efficacy and safety of standard term (12 months) or long term (> 12
months) dual antiplatelet therapy (DAPT) versus short term (< 6 months) DAPT after …

Background: Randomized controlled trials comparing short-(≤ 6 months) with long-term (≥
1 year) dual antiplatelet therapy (DAPT) after drug-eluting stent (s)(DES) placement have …

Objectives: This study sought to assess device-specific outcomes after implantation of bare-
metal stents (BMS), zotarolimus-eluting Endeavor Sprint stents (ZES-S), paclitaxel-eluting …